Stock Screener App

Frei -

Installieren

2.20

3.93% -0.09

Compass Therapeutics Inc (CMPX)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Compass Therapeutics Inc Aktie (CMPX) Neueste Nachrichten

CMPX Stock Has Retail Buzzing Ahead Of High-Stakes Cancer Drug Trial Update - Stocktwits

If You Invested $1,000 in Compass Therapeutics Inc (CMPX) - Stock Titan

Here’s Why Citizens Maintains a Buy on Compass Therapeutics (CMPX) - Insider Monkey

Bronstein, Gewirtz & Grossman, LLC Is Investigating Compass Thera - The National Law Review

Compass Showcases Promising Tovecimig Data, Eyes Commercialization - TipRanks

Compass updates corporate presentation, reports positive Phase 2/3 COMPANION-002 BTC data and plans BLA engagement - TradingView

Compass Therapeutics (NASDAQ: CMPX) targets BLA after biliary tract cancer trial success - Stock Titan

Compass Therapeutics (CMPX) 10K Form and Latest SEC Filings 2026 - MarketBeat

A Clinical-Stage Cancer Company Is Putting AI to Work Designing Its Next Generation of Tumor-Targeting Drugs - Sahm

Enterprise value to revenue forward of Compass Therapeutics, Inc. – NASDAQ:CMPX - TradingView

Price to sales forward of Compass Therapeutics, Inc. – NASDAQ:CMPX - TradingView

$Compass Therapeutics (CMPX.US)$ - Moomoo

Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000E Growth Benchmark - marketscreener.com

Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000 Growth Benchmark - marketscreener.com

Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 2000 Growth Benchmark - marketscreener.com

Compass Therapeutics Inc. (CMPX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Compass Therapeutics (CMPX) Stock Forecast & Analyst Ratings - Moomoo

Compass Therapeutics, Inc. Actuals & Estimates (NASDAQ:CMPX) - TradingView

CMPX Forecast — Price Target — Prediction for 2027 - TradingView

Compass Therapeutics Inc. (CMPX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Compass Therapeutics Adopts Second Amended and Restated Bylaws - The Globe and Mail

Compass Therapeutics Inc. (CMPX) Institutional Confidence - TradingKey

Compass Therapeutics Inc. (CMPX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Compass Therapeutics Inc. (CMPX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Compass Therapeutics Inc. (CMPX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

How Compass Therapeutics (CMPX) Is Moving Tovecimig Toward a Potential Biliary Tract Cancer Filing - Insider Monkey

Compass Therapeutics Inc. (CMPX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Compass Therapeutics Inc. (CMPX) Valuation: PE, PB & Fair Value Analysis - TradingKey

5 Small Cap Stocks with Potential to Rise 1000 Percent - Insider Monkey

Compass Therapeutics eyes FDA path after Tovecimig trial win - MSN

Compass Therapeutics Shareholders Back Directors, Pay, Auditor Oversight - The Globe and Mail

Compass Therapeutics (NASDAQ: CMPX) investors back board, auditor and pay in 2026 votes - Stock Titan

CMPX: Lead oncology asset tovecimig nears FDA filing after strong BTC trial results; multiple catalysts ahead - TradingView

Compass Therapeutics, Inc. (CMPX) Latest Stock News & Headlines - Yahoo Finance

Compass Therapeutics Eyes FDA Path After Tovecimig Trial Win - MarketBeat

CMPX News | COMPASS THERAPEUTICS INC (NASDAQ:CMPX) - ChartMill

Citizens reiterates Compass Therapeutics stock rating on ASCO data By Investing.com - Investing.com Nigeria

CMPX: Lead drug tovecimig showed strong efficacy in BTC; key FDA and data milestones expected this year - TradingView

CMPX Stock Chart | COMPASS THERAPEUTICS INC (NASDAQ:CMPX) - ChartMill

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Compass Therapeutics (CMPX) and Tenax Therapeutics (TENX) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Emergent Biosolutions (EBS) and Compass Therapeutics (CMPX) - The Globe and Mail

Piper Sandler Maintains Compass Therapeutics(CMPX.US) With Buy Rating, Cuts Target Price to $4 - Moomoo

Stifel reiterates Compass Therapeutics stock rating on ASCO data By Investing.com - Investing.com Canada

Number of shareholders of Compass Therapeutics, Inc. – NASDAQ:CMPX - TradingView

CMPX Q1 2026 Earnings: Narrow EPS Beat Drives Positive Stock ReactionTrough Earnings Signal - thelegaladvocate.com

Compass Therapeutics to Participate in Upcoming June Investor Events - Investing News Network

CMPXCompass Therapeutics Inc Latest SEC Filings - Finviz

Analysts Are Bullish on These Healthcare Stocks: Fortrea Holdings Inc. (FTRE), Cullinan Management (CGEM) - The Globe and Mail

Compass Therapeutics (CMPX) Breaks Above Support: What’s Driving the 4.6% MoveStrangle Setup - newsline.com

CMPX Q1 2026 Earnings: Narrowed Loss Beats Estimates, Stock Surges 7.25%Forward Guidance Trends - newsline.com

CCORF Maintains Compass Therapeutics(CMPX.US) With Buy Rating, Maintains Target Price $7 - Moomoo

Compass Therapeutics reports phase 1 data for CTX-8371 By Investing.com - Investing.com South Africa

Compass Therapeutics reports phase 1 data for CTX-8371 - Investing.com UK

INSM

$113.49

1.16%

ROIV

$35.27

0.23%

RPRX

$57.95

1.95%

ONC

$308.33

0.48%

MRNA

$82.23

0.32%

RVMD

$190.47

0.31%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters